位置:首页 > 蛋白库 > MOT1_RAT
MOT1_RAT
ID   MOT1_RAT                Reviewed;         494 AA.
AC   P53987;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   03-AUG-2022, entry version 164.
DE   RecName: Full=Monocarboxylate transporter 1;
DE            Short=MCT 1;
DE   AltName: Full=Solute carrier family 16 member 1;
GN   Name=Slc16a1; Synonyms=Mct1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   STRAIN=Wistar; TISSUE=Small intestine;
RX   PubMed=8526936; DOI=10.1006/bbrc.1995.2786;
RA   Takanaga H., Tamai I., Inaba S., Sai Y., Higashida H., Yamamoto H.,
RA   Tsuji A.;
RT   "cDNA cloning and functional characterization of rat intestinal
RT   monocarboxylate transporter.";
RL   Biochem. Biophys. Res. Commun. 217:370-377(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar; TISSUE=Skeletal muscle;
RX   PubMed=7548134; DOI=10.1016/0005-2736(95)00160-5;
RA   Jackson V.N., Price N.T., Halestrap A.P.;
RT   "cDNA cloning of MCT1, a monocarboxylate transporter from rat skeletal
RT   muscle.";
RL   Biochim. Biophys. Acta 1238:193-196(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 264-472, FUNCTION, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Jejunal epithelium;
RX   PubMed=10564700; DOI=10.1111/j.1469-445x.1999.01918.x;
RA   Orsenigo M.N., Tosco M., Bazzini C., Laforenza U., Faelli A.;
RT   "A monocarboxylate transporter MCT1 is located at the basolateral pole of
RT   rat jejunum.";
RL   Exp. Physiol. 84:1033-1042(1999).
RN   [5]
RP   INTERACTION WITH EMB, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=9169423; DOI=10.1074/jbc.272.23.14624;
RA   Poole R.C., Halestrap A.P.;
RT   "Interaction of the erythrocyte lactate transporter (monocarboxylate
RT   transporter 1) with an integral 70-kDa membrane glycoprotein of the
RT   immunoglobulin superfamily.";
RL   J. Biol. Chem. 272:14624-14628(1997).
RN   [6]
RP   INTERACTION WITH BSG, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11719518; DOI=10.1074/jbc.m109658200;
RA   Wilson M.C., Meredith D., Halestrap A.P.;
RT   "Fluorescence resonance energy transfer studies on the interaction between
RT   the lactate transporter MCT1 and CD147 provide information on the topology
RT   and stoichiometry of the complex in situ.";
RL   J. Biol. Chem. 277:3666-3672(2002).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-213, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16396499; DOI=10.1021/pr0503073;
RA   Moser K., White F.M.;
RT   "Phosphoproteomic analysis of rat liver by high capacity IMAC and LC-
RT   MS/MS.";
RL   J. Proteome Res. 5:98-104(2006).
RN   [8]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH BSG, TOPOLOGY,
RP   3D-STRUCTURE MODELING, AND MUTAGENESIS OF ARG-86; ARG-196; ASP-302 AND
RP   ARG-306.
RX   PubMed=17127621; DOI=10.1080/09687860600841967;
RA   Manoharan C., Wilson M.C., Sessions R.B., Halestrap A.P.;
RT   "The role of charged residues in the transmembrane helices of
RT   monocarboxylate transporter 1 and its ancillary protein basigin in
RT   determining plasma membrane expression and catalytic activity.";
RL   Mol. Membr. Biol. 23:486-498(2006).
RN   [9]
RP   FUNCTION, INTERACTION WITH EMB, SUBCELLULAR LOCATION, TOPOLOGY,
RP   3D-STRUCTURE MODELING, MUTAGENESIS OF LYS-38; LYS-45; LYS-282; LYS-284;
RP   LYS-290 AND LYS-413, ACTIVITY REGULATION, AND TISSUE SPECIFICITY.
RX   PubMed=19473976; DOI=10.1074/jbc.m109.014217;
RA   Wilson M.C., Meredith D., Bunnun C., Sessions R.B., Halestrap A.P.;
RT   "Studies on the DIDS-binding site of monocarboxylate transporter 1 suggest
RT   a homology model of the open conformation and a plausible translocation
RT   cycle.";
RL   J. Biol. Chem. 284:20011-20021(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210; SER-213; SER-220;
RP   SER-230; SER-460 AND SER-492, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Proton-coupled monocarboxylate transporter. Catalyzes the
CC       rapid transport across the plasma membrane of many monocarboxylates
CC       such as lactate, pyruvate, branched-chain oxo acids derived from
CC       leucine, valine and isoleucine, and the ketone bodies acetoacetate,
CC       beta-hydroxybutyrate and acetate. Depending on the tissue and on
CC       cicumstances, mediates the import or export of lactic acid and ketone
CC       bodies. Required for normal nutrient assimilation, increase of white
CC       adipose tissue and body weight gain when on a high-fat diet. Plays a
CC       role in cellular responses to a high-fat diet by modulating the
CC       cellular levels of lactate and pyruvate, small molecules that
CC       contribute to the regulation of central metabolic pathways and insulin
CC       secretion, with concomitant effects on plasma insulin levels and blood
CC       glucose homeostasis. {ECO:0000269|PubMed:10564700,
CC       ECO:0000269|PubMed:11719518, ECO:0000269|PubMed:17127621,
CC       ECO:0000269|PubMed:19473976, ECO:0000269|PubMed:8526936}.
CC   -!- ACTIVITY REGULATION: Inhibited by stilbene disulfonates, such as di-
CC       isothiocyanostilbene disulfonate(DIDS), a cross-linking reagent that
CC       forms covalent linkages with lysine groups.
CC       {ECO:0000269|PubMed:19473976}.
CC   -!- SUBUNIT: Interacts with BSG. Interacts with EMB. Interaction with
CC       either BSG or EMB is required for expression at the cell membrane.
CC       {ECO:0000269|PubMed:11719518, ECO:0000269|PubMed:17127621,
CC       ECO:0000269|PubMed:19473976, ECO:0000269|PubMed:9169423}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:10564700,
CC       ECO:0000269|PubMed:11719518, ECO:0000269|PubMed:17127621,
CC       ECO:0000269|PubMed:19473976, ECO:0000269|PubMed:8526936,
CC       ECO:0000269|PubMed:9169423}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:10564700, ECO:0000269|PubMed:11719518,
CC       ECO:0000269|PubMed:17127621, ECO:0000269|PubMed:19473976,
CC       ECO:0000269|PubMed:8526936, ECO:0000269|PubMed:9169423}.
CC   -!- TISSUE SPECIFICITY: Detected in erythrocytes (at protein level).
CC       Detected in brain, heart, kidney, lung, muscle, jejunum enterocytes and
CC       brain capillaries. {ECO:0000269|PubMed:10564700,
CC       ECO:0000269|PubMed:19473976, ECO:0000269|PubMed:8526936,
CC       ECO:0000269|PubMed:9169423}.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily.
CC       Monocarboxylate porter (TC 2.A.1.13) family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D63834; BAA09894.1; -; mRNA.
DR   EMBL; X86216; CAA60116.1; -; mRNA.
DR   EMBL; BC078877; AAH78877.1; -; mRNA.
DR   EMBL; AJ236865; CAB37948.1; -; mRNA.
DR   PIR; JC4399; JC4399.
DR   RefSeq; NP_036848.1; NM_012716.2.
DR   RefSeq; XP_017446125.1; XM_017590636.1.
DR   AlphaFoldDB; P53987; -.
DR   SMR; P53987; -.
DR   BioGRID; 247107; 2.
DR   IntAct; P53987; 1.
DR   STRING; 10116.ENSRNOP00000027234; -.
DR   BindingDB; P53987; -.
DR   ChEMBL; CHEMBL2073709; -.
DR   iPTMnet; P53987; -.
DR   PhosphoSitePlus; P53987; -.
DR   jPOST; P53987; -.
DR   PaxDb; P53987; -.
DR   PRIDE; P53987; -.
DR   Ensembl; ENSRNOT00000027234; ENSRNOP00000027234; ENSRNOG00000019996.
DR   GeneID; 25027; -.
DR   KEGG; rno:25027; -.
DR   UCSC; RGD:3690; rat.
DR   CTD; 6566; -.
DR   RGD; 3690; Slc16a1.
DR   eggNOG; KOG2504; Eukaryota.
DR   GeneTree; ENSGT00940000154955; -.
DR   HOGENOM; CLU_001265_59_1_1; -.
DR   InParanoid; P53987; -.
DR   OMA; TYAGFCI; -.
DR   OrthoDB; 916876at2759; -.
DR   PhylomeDB; P53987; -.
DR   TreeFam; TF313792; -.
DR   Reactome; R-RNO-210991; Basigin interactions.
DR   Reactome; R-RNO-433692; Proton-coupled monocarboxylate transport.
DR   Reactome; R-RNO-70268; Pyruvate metabolism.
DR   Reactome; R-RNO-9749641; Aspirin ADME.
DR   SABIO-RK; P53987; -.
DR   PRO; PR:P53987; -.
DR   Proteomes; UP000002494; Chromosome 2.
DR   Bgee; ENSRNOG00000019996; Expressed in heart and 19 other tissues.
DR   Genevisible; P53987; RN.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0009925; C:basal plasma membrane; ISO:RGD.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:ARUK-UCL.
DR   GO; GO:0005813; C:centrosome; ISO:RGD.
DR   GO; GO:0016021; C:integral component of membrane; IBA:GO_Central.
DR   GO; GO:0005887; C:integral component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IEA:Ensembl.
DR   GO; GO:0016328; C:lateral plasma membrane; ISO:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:RGD.
DR   GO; GO:0045202; C:synapse; ISO:RGD.
DR   GO; GO:0046943; F:carboxylic acid transmembrane transporter activity; IMP:ARUK-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:RGD.
DR   GO; GO:0015129; F:lactate transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0008028; F:monocarboxylic acid transmembrane transporter activity; IDA:ARUK-UCL.
DR   GO; GO:0097159; F:organic cyclic compound binding; IMP:RGD.
DR   GO; GO:0015293; F:symporter activity; IEA:UniProtKB-KW.
DR   GO; GO:0051780; P:behavioral response to nutrient; ISO:RGD.
DR   GO; GO:1905039; P:carboxylic acid transmembrane transport; IMP:ARUK-UCL.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IMP:RGD.
DR   GO; GO:0007098; P:centrosome cycle; ISO:RGD.
DR   GO; GO:0042593; P:glucose homeostasis; ISO:RGD.
DR   GO; GO:0035873; P:lactate transmembrane transport; IDA:RGD.
DR   GO; GO:0006629; P:lipid metabolic process; ISO:RGD.
DR   GO; GO:0015718; P:monocarboxylic acid transport; IDA:ARUK-UCL.
DR   GO; GO:0035879; P:plasma membrane lactate transport; IDA:RGD.
DR   GO; GO:0050796; P:regulation of insulin secretion; ISO:RGD.
DR   GO; GO:0032094; P:response to food; ISO:RGD.
DR   Gene3D; 1.20.1250.20; -; 1.
DR   InterPro; IPR004743; MCT.
DR   InterPro; IPR030757; MCT1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   InterPro; IPR036259; MFS_trans_sf.
DR   PANTHER; PTHR11360:SF24; PTHR11360:SF24; 1.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 1.
DR   TIGRFAMs; TIGR00892; 2A0113; 1.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Membrane; Phosphoprotein; Reference proteome; Symport;
KW   Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..494
FT                   /note="Monocarboxylate transporter 1"
FT                   /id="PRO_0000211384"
FT   TOPO_DOM        1..15
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        16..36
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        37..59
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        60..80
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        81..86
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        87..107
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        108..111
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        112..132
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        133..143
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        144..164
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        165..166
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        167..187
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        188..255
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        256..276
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        277..291
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        292..312
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        313..321
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        322..342
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        343..346
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        347..367
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        368..382
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        383..403
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        404..415
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        416..436
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        437..494
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          446..494
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        446..472
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        474..494
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         210
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16396499,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         220
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         224
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P53986"
FT   MOD_RES         230
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         459
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P53985"
FT   MOD_RES         460
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         461
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P53986"
FT   MOD_RES         476
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P53985"
FT   MOD_RES         483
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P53986"
FT   MOD_RES         484
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P53986"
FT   MOD_RES         492
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MUTAGEN         38
FT                   /note="K->Q,R: No effect on expression at the cell
FT                   membrane, but abolishes lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:19473976"
FT   MUTAGEN         45
FT                   /note="K->Q,R: No effect on expression at the cell
FT                   membrane. No effect on lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:19473976"
FT   MUTAGEN         86
FT                   /note="R->E,Q: No effect on expression at the cell
FT                   membrane. No effect on lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:17127621"
FT   MUTAGEN         196
FT                   /note="R->E,Q: No effect on expression at the cell
FT                   membrane. No effect on lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:17127621"
FT   MUTAGEN         282
FT                   /note="K->Q,R: No effect on expression at the cell
FT                   membrane. No effect on lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:19473976"
FT   MUTAGEN         284
FT                   /note="K->Q,R: No effect on expression at the cell
FT                   membrane. No effect on lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:19473976"
FT   MUTAGEN         290
FT                   /note="K->Q,R: No effect on expression at the cell
FT                   membrane. No effect on lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:19473976"
FT   MUTAGEN         302
FT                   /note="D->R: Abolishes expression at the cell membrane.
FT                   Abolishes lactate transport across the cell membrane
FT                   without affecting expression at the cell membrane; when
FT                   associated with E-306."
FT                   /evidence="ECO:0000269|PubMed:17127621"
FT   MUTAGEN         306
FT                   /note="R->E: Abolishes expression at the cell membrane.
FT                   Abolishes lactate transport across the cell membrane
FT                   without affecting expression at the cell membrane; when
FT                   associated with R-302."
FT                   /evidence="ECO:0000269|PubMed:17127621"
FT   MUTAGEN         306
FT                   /note="R->K: No effect on expression at the cell membrane,
FT                   but abolishes lactate transport across the cell membrane."
FT                   /evidence="ECO:0000269|PubMed:17127621"
FT   MUTAGEN         413
FT                   /note="K->Q,R: No effect on expression at the cell
FT                   membrane. No effect on lactate transport across the cell
FT                   membrane."
FT                   /evidence="ECO:0000269|PubMed:19473976"
SQ   SEQUENCE   494 AA;  53238 MW;  CF82F8794CDBF057 CRC64;
     MPPAIGGPVG YTPPDGGWGW AVVVGAFISI GFSYAFPKSI TVFFKEIEII FSATTSEVSW
     ISSIMLAVMY AGGPISSILV NKYGSRPVMI AGGCLSGCGL IAASFCNTVQ ELYFCIGVIG
     GLGLAFNLNP ALTMIGKYFY KKRPLANGLA MAGSPVFLST LAPLNQAFFG IFGWRGSFLI
     LGGLLLNCCV AGSLMRPIGP QQGKVEKLKS KESLQEAGKS DANTDLIGGS PKGEKLSVFQ
     TVNKFLDLSL FTHRGFLLYL SGNVVMFFGL FTPLVFLSNY GKSKHFSSEK SAFLLSILAF
     VDMVARPSMG LAANTRWIRP RVQYFFAASV VANGVCHLLA PLSTTYVGFC IYAGVFGFAF
     GWLSSVLFET LMDLVGPQRF SSAVGLVTIV ECCPVLLGPP LLGRLNDMYG DYKYTYWACG
     VILIIAGLYL FIGMGINYRL VAKEQKAEEK KRDGKEDETS TDVDEKPKKT MKETQSPAPL
     QNSSGDPAEE ESPV
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024